Literature DB >> 11840182

Lipid-lowering effects of a modified butter-fat: a controlled intervention trial in healthy men.

S D Poppitt1, G F Keogh, T B Mulvey, B H McArdle, A K H MacGibbon, G J S Cooper.   

Abstract

OBJECTIVE: To investigate the lipid-lowering potential of a butter-fat modified through manipulations in bovine feeding to increase the unsaturated:saturated fatty acid ratio.
DESIGN: Double-blind, randomised, cross-over intervention trial.
SETTING: University of Auckland Human Nutrition Unit, New Zealand.
SUBJECTS: Twenty healthy, male subjects. INTERVENTION: A residential trial in which all foods and beverages were provided during two intervention periods, comprising 3 weeks of high unsaturated 'modified' vs. 3 weeks of saturated 'control' butter feeding separated by a 4 week washout. Diets were of typical composition of 39 percentage energy (en%) fat (20 en% butter-fat), 48 en% CHO, 13 en% protein.
RESULTS: There was a significant decrease in both total (P<0.05, -7.9%) and LDL-cholesterol (P<0.01, -9.5%) during modified butter feeding. There was no significant effect of treatment on a range of other risk factors including HDL-cholesterol, triglyceride, apolipoprotein A or B, nonesterified fatty acids (NEFA), haemostatic clotting factor VII and fibrinogen or glucose (P>0.05). Subjects were maintained in energy balance and there was no significant change in body weight during intervention. Butter-fat composition alone differed between treatments.
CONCLUSIONS: A significant improvement in cardiovascular risk can be achieved by moderate changes in dietary fatty acid profile, achieved through a common and well accepted food source, butter-fat.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11840182     DOI: 10.1038/sj.ejcn.1601282

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  7 in total

1.  Assessment of erythrocyte phospholipid fatty acid composition as a biomarker for dietary MUFA, PUFA or saturated fatty acid intake in a controlled cross-over intervention trial.

Authors:  Sally D Poppitt; Paul Kilmartin; Paul Butler; Geraldine F Keogh
Journal:  Lipids Health Dis       Date:  2005-12-05       Impact factor: 3.876

2.  Chemical composition and pharmacological significance of Anethum Sowa L. Root.

Authors:  Md Moshfekus Saleh-E-In; Nasim Sultana; Md Matiur Rahim; Md Aminul Ahsan; Md Nurul Huda Bhuiyan; Md Nur Hossain; Md Mahbubar Rahman; Sudhangshu Kumar Roy; Md Rabiul Islam
Journal:  BMC Complement Altern Med       Date:  2017-02-23       Impact factor: 3.659

3.  Nonfat milk attenuates acute hyperglycemia in individuals with android obesity: A randomized control trial.

Authors:  Miriam P Leary; Stephen J Roy; Jisok Lim; Wonil Park; Rodrigo Ferrari; Jared Eaves; Daniel R Machin; Hirofumi Tanaka
Journal:  Food Sci Nutr       Date:  2018-09-12       Impact factor: 2.863

Review 4.  Role of Fluid Milk in Attenuating Postprandial Hyperglycemia and Hypertriglyceridemia.

Authors:  Miriam Leary; Hirofumi Tanaka
Journal:  Nutrients       Date:  2020-12-11       Impact factor: 5.717

5.  Effects of butter from mountain-pasture grazing cows on risk markers of the metabolic syndrome compared with conventional Danish butter: a randomized controlled study.

Authors:  Louise B Werner; Lars I Hellgren; Marianne Raff; Søren K Jensen; Rikke A Petersen; Tue Drachmann; Tine Tholstrup
Journal:  Lipids Health Dis       Date:  2013-07-10       Impact factor: 3.876

6.  Seasonal Variation in Fat Quality and Conjugated Linoleic Acid Content of Dairy Products from the Tropics: Evidence of Potential Impact on Human Health.

Authors:  Juliana Côrtes Nunes; Monalisa Nilza Lole Ramalho da Silva; Daniel Perrone; Alexandre Guedes Torres
Journal:  Foods       Date:  2017-08-01

7.  Effects of Breed and Stage of Lactation on Milk Fatty Acid Composition of Italian Goat Breeds.

Authors:  Sarah Currò; Carmen L Manuelian; Massimo De Marchi; Salvatore Claps; Domenico Rufrano; Gianluca Neglia
Journal:  Animals (Basel)       Date:  2019-10-03       Impact factor: 2.752

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.